Discover the Evexia advantage Start ordering today
Take advantage of all the time and money-saving features that Evexia Diagnostics has to offer. Simply click the button below to get started.
Register NowTurnaround Time: 21 business days
Test Type: Whole Blood
Overview:
The Precision Epigenomics liquid biopsy test, EPISEEK™, is a blood-based test designed to accurately assess DNA shed by tumors called “circulating tumor DNA” (ctDNA). EPISEEK™ detects cancer-specific aberrant DNA methylation cell-free DNA, targeting a proprietary set of biomarkers that reliably indicate the presence of cancer (this molecular signature is not found in normal cells).
Using advanced technology software, epigenomic modifications are analyzed. This technology is cost-effective, precise, minimally invasive, and may detect cancer earlier than imaging. It is also more accessible than a tissue biopsy.
*Only orderable for licensed physicians*